TOKYO -- Japan has entered into talks with AstraZeneca to supply a portion of its share of the company's coronavirus vaccine to Taiwan as the island struggles with a spike in cases.
Japan's agreement with AstraZeneca for 120 million doses of the two-shot vaccine includes a clause barring vaccines from being transferred to other destinations -- a stipulation found in many COVID-19 vaccine contracts. The health ministry is negotiating with AstraZeneca to modify the contract to allow shipments to Taiwan.